As medical technology develops, there is continued hope in the battle against breast cancer. Please note that Dr. Higgins does not necessarily endorse any or all of the methods listed here. This page is a repository of information you can use in your search to better understand the current state of breast cancer research.
DNA-based Cancer Vaccine Triggers Immune System
Researchers think it may be possible to create personalized cancer vaccines by using DNA. The aim is to program the immune system to attack tumors — including breast cancer malignancies. The work is similar to the research that created the Pfizer and Moderna COVID-19 vaccines. The work is being funded by Susan G. Komen for the Cure, the NIH, and others. For the full article click here.
SERDs in Advanced ER+ Breast Cancer
Studies show that the selective estrogen receptor degrader (SERD) amcenestrant may prove helpful in patients with estrogen receptor positive (ER+) breast cancer. Ongoing research is in progress. For now, though, breast cancer specialists are in a wait and see mode. For the full article click here.
The Micro-environment of Breast Cancer in Three Dimensions
Researchers at Penn State have developed a platform that will allow the culture and study of breast cancer tumors. The work could add to our understanding of how the tumors interact with their environment. The focus is especially aimed at breast cancer tumors that have so far been difficult to treat. For the full article click here.
Aggressive Breast Cancer Research Promising
Research scientists are working to prove the efficacy of a two-drug targeted therapy for triple negative breast cancer (TNBC). One of the researchers had this to say: “What we found was beyond our expectations: the two drugs acted in a synergistic manner and efficiently reduced tumor growth in vitro as well as in vivo, using cell- and patient-derived xenograft models of TNBC.” For the full article click here.
Statin Drugs May Help in Breast Cancer Treatment
A study by the University of Toronto found that statin drugs (normally prescribed to lower cholesterol) may help prevent damage to the heart muscle during chemotherapy. The research is supported by previous studies. Data collected from cases involving over 2,000 Canadian women revealed the following:
Results indicated that patients who were prescribed anthracyclines as well as statins were 55 percent less likely to develop heart failure. Patients who were prescribed trastuzumab as well as statins were 54 percent less likely to develop the condition.
To read more, click here.